Travere Therapeutics, Inc. (TVTX)
65.22
-0.49
(-0.75%)
USD |
NASDAQ |
Aug 24, 16:00
65.22
0.00 (0.00%)
After-Hours: 20:00
Travere Therapeutics Debt to Equity Ratio : 25.16 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 25.16 |
| March 31, 2026 | 3.319 |
| December 31, 2025 | 2.863 |
| September 30, 2025 | 4.482 |
| June 30, 2025 | 12.20 |
| March 31, 2025 | 12.20 |
| December 31, 2024 | 6.798 |
| September 30, 2024 | -13.21 |
| June 30, 2024 | 26.62 |
| March 31, 2024 | 5.454 |
| December 31, 2023 | 2.016 |
| September 30, 2023 | 1.449 |
| June 30, 2023 | 3.487 |
| March 31, 2023 | 2.151 |
| December 31, 2022 | 9.509 |
| September 30, 2022 | 4.049 |
| June 30, 2022 | 2.605 |
| March 31, 2022 | 1.964 |
| December 31, 2021 | 0.8672 |
| September 30, 2021 | 0.8459 |
| June 30, 2021 | 0.7716 |
| March 31, 2021 | 0.6903 |
| December 31, 2020 | 1.155 |
| September 30, 2020 | 0.8008 |
| June 30, 2020 | 0.685 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.9297 |
| December 31, 2019 | 0.9714 |
| September 30, 2019 | 0.8653 |
| June 30, 2019 | 0.7608 |
| March 31, 2019 | 0.8118 |
| December 31, 2018 | 0.6836 |
| September 30, 2018 | 0.6743 |
| June 30, 2018 | 0.1576 |
| March 31, 2018 | 0.1511 |
| December 31, 2017 | 0.1538 |
| September 30, 2017 | 0.1475 |
| June 30, 2017 | 0.1513 |
| March 31, 2017 | 0.1481 |
| December 31, 2016 | 0.1443 |
| September 30, 2016 | 0.1439 |
| June 30, 2016 | 0.1403 |
| March 31, 2016 | 0.1376 |
| December 31, 2015 | 0.1464 |
| September 30, 2015 | 0.1503 |
| June 30, 2015 | 0.5619 |
| March 31, 2015 | 0.4998 |
| December 31, 2014 | -2.249 |
| September 30, 2014 | -8.176 |
| June 30, 2014 | 77.63 |
| March 31, 2014 | -0.8839 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| AbbVie, Inc. | -11.93 |
| Insmed, Inc. | 0.9865 |
| United Therapeutics Corp. | 0.00 |
| Krystal Biotech, Inc. | 0.0065 |
| Relay Therapeutics, Inc. | 0.0344 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 799.36M |
| Total Liabilities (Quarterly) | 774.84M |
| Shareholders Equity (Quarterly) | 24.52M |
| Current Ratio | 4.046 |
| Net Debt Paydown Yield | -0.81% |